1. Home
  2. ALT vs FRA Comparison

ALT vs FRA Comparison

Compare ALT & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • FRA
  • Stock Information
  • Founded
  • ALT 1997
  • FRA 2003
  • Country
  • ALT United States
  • FRA United States
  • Employees
  • ALT N/A
  • FRA N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • FRA Investment Bankers/Brokers/Service
  • Sector
  • ALT Health Care
  • FRA Finance
  • Exchange
  • ALT Nasdaq
  • FRA Nasdaq
  • Market Cap
  • ALT 472.3M
  • FRA 449.1M
  • IPO Year
  • ALT N/A
  • FRA N/A
  • Fundamental
  • Price
  • ALT $4.07
  • FRA $13.19
  • Analyst Decision
  • ALT Strong Buy
  • FRA
  • Analyst Count
  • ALT 6
  • FRA 0
  • Target Price
  • ALT $20.20
  • FRA N/A
  • AVG Volume (30 Days)
  • ALT 10.1M
  • FRA 165.4K
  • Earning Date
  • ALT 08-07-2025
  • FRA 01-01-0001
  • Dividend Yield
  • ALT N/A
  • FRA 11.06%
  • EPS Growth
  • ALT N/A
  • FRA N/A
  • EPS
  • ALT N/A
  • FRA N/A
  • Revenue
  • ALT $20,000.00
  • FRA N/A
  • Revenue This Year
  • ALT N/A
  • FRA N/A
  • Revenue Next Year
  • ALT $1,557,547.90
  • FRA N/A
  • P/E Ratio
  • ALT N/A
  • FRA N/A
  • Revenue Growth
  • ALT N/A
  • FRA N/A
  • 52 Week Low
  • ALT $2.90
  • FRA $11.33
  • 52 Week High
  • ALT $11.16
  • FRA $13.10
  • Technical
  • Relative Strength Index (RSI)
  • ALT 33.67
  • FRA 68.56
  • Support Level
  • ALT $3.30
  • FRA $12.85
  • Resistance Level
  • ALT $4.04
  • FRA $12.96
  • Average True Range (ATR)
  • ALT 0.61
  • FRA 0.10
  • MACD
  • ALT -0.40
  • FRA 0.02
  • Stochastic Oscillator
  • ALT 19.49
  • FRA 96.41

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.

Share on Social Networks: